Review
doi: 10.1007/BF03165048.
Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders
Affiliations
- PMID: 8814734
- DOI: 10.1007/BF03165048
Item in Clipboard
Review
Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders
Ann Nucl Med.
1996 Feb.
No abstract available
Similar articles
-
Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues.Semin Nucl Med. 1995 Jul;25(3):272-8. doi: 10.1016/s0001-2998(95)80016-6. Semin Nucl Med. 1995. PMID: 7570046 Review.
-
The treatment of neuroblastoma with 131I-MIBG.Med Pediatr Oncol. 1987;15(4):157-8. doi: 10.1002/mpo.2950150403. Med Pediatr Oncol. 1987. PMID: 3657703 No abstract available.
-
[131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].Rinsho Hoshasen. 1987 Apr;32(4):461-70. Rinsho Hoshasen. 1987. PMID: 3613180 Japanese. No abstract available.
-
Radionuclide therapy of pheochromocytomas and neuroblastomas using iodine-131 metaiodobenzylguanidine (MIBG).Clin Nucl Med. 1989 Jan;14(1):19-21. doi: 10.1097/00003072-198901000-00006. Clin Nucl Med. 1989. PMID: 2714036 No abstract available.
-
[Iodine-131 meta-iodobenzylguanidine for the diagnosis and treatment of pheochromocytoma and tumors of neural crest origin].Harefuah. 1992 Apr 15;122(8):526-9. Harefuah. 1992. PMID: 1398325 Review. Hebrew. No abstract available.